CliffBio
small molecule

HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE

CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE

Loss of exclusivity—loss of exclusivity
CompanyTris. →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE
Active ingredientCHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE
Strength4MG/5ML;5MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2015
Marketing statusDISCN

More from Tris.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE patent cliff — loss of exclusivity — | CliffBio